Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation
James I. Andorko, Ronnie M. Russell, Bruce C. Schnepp, Daniel Grubaugh, Karla F Mullen, Aoi Wakabayashi, Léolène J Carrington, Thomas O’Malley, Leticia Kuri-Cervantes, Timothy D. Culp, Philip R. Johnson
Topics & Concepts
In vivoViral vectorGene deliveryVector (molecular biology)LentivirusVirologyGenetic enhancementBiologyComputational biologyGeneticsGeneRecombinant DNAVirusViral diseaseCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in InsectsRNA Interference and Gene Delivery